These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


373 related items for PubMed ID: 26521452

  • 1. [Preparation and evaluation of risperidone-loaded microsphere/sucrose acetate isobutyrate in situ forming complex depot with double diffusion barriers].
    Lin X, Tang X, Xu YH, Zhang Y, Zhang Y, He HB.
    Yao Xue Xue Bao; 2015 Jun; 50(6):775-82. PubMed ID: 26521452
    [Abstract] [Full Text] [Related]

  • 2. A Uniform Ultra-Small Microsphere/SAIB Hybrid Depot with Low Burst Release for Long-Term Continuous Drug Release.
    Lin X, Xu Y, Tang X, Zhang Y, Chen J, Zhang Y, He H, Yang Z.
    Pharm Res; 2015 Nov; 32(11):3708-21. PubMed ID: 26077999
    [Abstract] [Full Text] [Related]

  • 3. Tracking the effect of microspheres size on the drug release from a microsphere/sucrose acetate isobutyrate (SAIB) hybrid depot in vitro and in vivo.
    Lin X, Wang J, Xu Y, Tang X, Chen J, Zhang Y, Zhang Y, Yang Z.
    Drug Dev Ind Pharm; 2016 Sep; 42(9):1455-65. PubMed ID: 26790718
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Sucrose acetate isobutyrate as an in situ forming system for sustained risperidone release.
    Lu Y, Yu Y, Tang X.
    J Pharm Sci; 2007 Dec; 96(12):3252-62. PubMed ID: 17721936
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In vitro study of lysozyme in poly(lactide-co-glycolide) microspheres with sucrose acetate isobutyrate.
    Lee ES, Kwon MJ, Lee H, Na K, Kim JJ.
    Eur J Pharm Sci; 2006 Dec; 29(5):435-41. PubMed ID: 16978848
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Electrosprayed minocycline hydrochloride-loaded microsphere/SAIB hybrid depot for periodontitis treatment.
    Zhang T, Qiu Y, Song J, Zhou P, Liao H, Cheng Y, Wu X.
    Drug Deliv; 2021 Dec; 28(1):620-633. PubMed ID: 33779441
    [Abstract] [Full Text] [Related]

  • 11. Formation Mechanism and In Vitro Evaluation of Risperidone-Containing PLGA Microspheres Fabricated by Ultrafine Particle Processing System.
    Huang Z, Chen X, Fu H, Wen X, Ma C, Zhang J, Wu C, Huang Y, Pan X, Wu C.
    J Pharm Sci; 2017 Nov; 106(11):3363-3371. PubMed ID: 28736289
    [Abstract] [Full Text] [Related]

  • 12. Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(D,L-lactide-co-glycolide) microsphere.
    Su Z, Sun F, Shi Y, Jiang C, Meng Q, Teng L, Li Y.
    Chem Pharm Bull (Tokyo); 2009 Nov; 57(11):1251-6. PubMed ID: 19881277
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. An Accelerated Release Method of Risperidone Loaded PLGA Microspheres with Good IVIVC.
    Hu X, Zhang J, Tang X, Li M, Ma S, Liu C, Gao Y, Zhang Y, Liu Y, Yu F, Yang Y, Guo J, Li Z, Mei X.
    Curr Drug Deliv; 2018 Nov; 15(1):87-96. PubMed ID: 28521697
    [Abstract] [Full Text] [Related]

  • 15. Raloxifene-/raloxifene-poly(ethylene glycol) conjugate-loaded microspheres: A novel strategy for drug delivery to bone forming cells.
    Kavas A, Keskin D, Altunbaş K, Tezcaner A.
    Int J Pharm; 2016 Aug 20; 510(1):168-83. PubMed ID: 27343363
    [Abstract] [Full Text] [Related]

  • 16. Sustained release of risperidone from biodegradable microspheres prepared by in-situ suspension-evaporation process.
    An T, Choi J, Kim A, Lee JH, Nam Y, Park J, Sun Bk, Suh H, Kim CJ, Hwang SJ.
    Int J Pharm; 2016 Apr 30; 503(1-2):8-15. PubMed ID: 26899975
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Influence of drying processes on the structures, morphology and in vitro release profiles of risperidone-loaded PLGA microspheres.
    Wu Z, Zhao M, Zhang W, Yang Z, Xu S, Shang Q.
    J Microencapsul; 2019 Jan 30; 36(1):21-31. PubMed ID: 30757946
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Microsphere delivery of Risperidone as an alternative to combination therapy.
    D'Souza S, Faraj J, DeLuca P.
    Eur J Pharm Biopharm; 2013 Nov 30; 85(3 Pt A):631-9. PubMed ID: 23892159
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.